177Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer
EA Salvanou, A Kolokithas-Ntoukas, D Prokopiou… - Molecules, 2024 - mdpi.com
The use of conventional methods for the treatment of cancer, such as chemotherapy or
radiotherapy, and approaches such as brachytherapy in conjunction with the unique …
radiotherapy, and approaches such as brachytherapy in conjunction with the unique …
Why and how optical molecular imaging should further be catalyzed by nuclear medicine and molecular imaging: report from the EANM piloting group
J Vonk, R Dierckx, S Keereweer, AL Vahrmeijer… - European Journal of …, 2024 - Springer
European Journal of Nuclear Medicine and Molecular Imaging hurdles, it becomes
increasingly evident that the NM community could play a pivotal role in this process, as …
increasingly evident that the NM community could play a pivotal role in this process, as …
PYTA: a universal chelator for advancing the theranostic palette of nuclear medicine
To clinically advance the growing arsenal of radiometals available to image and treat
cancer, chelators with versatile binding properties are needed. Herein, we evaluated the …
cancer, chelators with versatile binding properties are needed. Herein, we evaluated the …
Development of the occupational exposure during the production and application of radiopharmaceuticals in Germany
J Vogt, U Oeh, FJ Maringer - Journal of Radiological Protection, 2024 - iopscience.iop.org
An increasing number of radiopharmaceuticals and proteins are available for diagnosing
and treating various diseases. The demand for existing and newly developed …
and treating various diseases. The demand for existing and newly developed …
“Particle therapy-future for the Baltic states?”–synthesis of the expert workshop report
K Paļskis, E Korobeinikova, D Bogorada-Saukuma… - Health and …, 2024 - Springer
Abstract Background Baltic States remains one of the few regions in the Europe without a
dedicated particle therapy center. An initiative since 2021 has been started by CERN Baltic …
dedicated particle therapy center. An initiative since 2021 has been started by CERN Baltic …
Verification on Molybdenum-99 (99Mo) Breakthrough from Non-Fission 99Mo/99mTc Generator to Produce Technetium-99m (99mTc) Medical Radionuclide
NZ Ramadhanti, S Febriana - Journal of Physics: Conference …, 2024 - iopscience.iop.org
The medical radionuclide 99m Tc is the most widely used type of radionuclide in the field of
nuclear medicine. 99m Tc is the decay product of 99 Mo. One of the quality control …
nuclear medicine. 99m Tc is the decay product of 99 Mo. One of the quality control …